 |
Inhibitor of Tissue Factor Pathway Inhibitor (TFPI) |
|---|---|
| Trade Name | |
| Orphan Indication | Hemophilia A |
| USA Market Approval | USA |
| USA Designation Date | 2010-01-29 00:00:00 |
| Sponsor | Baxter Healthcare Corporation, Baxter BioScience;One Baxter Way;Westlake Village, California, 91362 |
Related Access Program
Joanne Kurtzberg, MD – Hypoxia Ischemia, Cerebral
Genentech, Inc. – Hemophilia A
GlaxoSmithKline – Systemic Lupus Erythematosus
Vitreous -Retina- Macula Consultants of New York – Retinal Hemangioma
Xiaofan Zhu – Hematopoiesis Maintainance.
Seoul National University Hospital – Chemical Burn
Paolo Caimi, MD – Hematopoietic/Lymphoid Cancer
Zimmer Biomet – Critical Limb Ischemia